“2025 was a transition year for Indivior (INDV) in which we established the Indivior Action Agenda and completed Phase I – Generate Momentum – by growing U.S. SUBLOCADE net revenue, simplifying the organization and transforming our operating model,” said Joe Ciaffoni, Chief Executive Officer. “We enter 2026 well positioned to execute on Phase II – Accelerate – which includes accelerating U.S. SUBLOCADE dispense unit growth and SUBLOCADE net revenue throughout 2026 and immediately accelerating adjusted EBITDA and cash flow at a faster rate.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INDV:
- Indivior Added to S&P SmallCap 600, Enhancing Visibility
- Indivior approves executive salary increases for senior leadership
- Indivior announces results from randomized, double-blind trial of SUBLOCADE
- Indivior’s INDV-2000 Study Completion: A Potential Game-Changer for Opioid Use Disorder
- Indivior Shareholders Approve Scheme of Arrangement